Sliskovic; Drago Robert
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sliskovic; Drago Robert.The latest application filed is for "oxabicyclo[4.1.0]hept-b-en-s-yl carbamoyl derivatives inhibiting the nuclear factor-kappa (b) - (nf-kb)".
- Sliskovic; Drago Robert - Chelsea MI US
- Sliskovic; Drago Robert - Saline MI
- Sliskovic; Drago Robert - Ypsilanti MI
| Patent | Date |
|---|---|
| Inhibitors of NF-.kappa.B Grant 8,629,164 - Zhang , et al. January 14, 2 | 2014-01-14 |
| Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting The Nuclear Factor-Kappa (B) - (NF-KB) App 20120088827 - Zhang; Jie ; et al. | 2012-04-12 |
| Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB) App 20120046357 - Zhang; Jie ; et al. | 2012-02-23 |
| Inhibitors of NF-KB App 20120015952 - Zhang; Jie ; et al. | 2012-01-19 |
| 3-isoquinolinone derivatives as matrix metalloproteinase inhibitors Grant 6,974,822 - Bunker , et al. December 13, 2 | 2005-12-13 |
| 6,5-Fused bicyclic heterocycles Grant 6,943,174 - Picard , et al. September 13, 2 | 2005-09-13 |
| 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase Grant 6,906,094 - Barvian , et al. June 14, 2 | 2005-06-14 |
| Method of inhibiting matrix metalloproteinases Grant 6,906,092 - O'Brien , et al. June 14, 2 | 2005-06-14 |
| 1, 2, 4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase App 20040053983 - Barvian, Nicole Chantel ; et al. | 2004-03-18 |
| 3-Isoquinolinone derivatives as matrix metalloproteinase inhibitors App 20040038959 - Bunker, Amy Mae ; et al. | 2004-02-26 |
| Method of inhibiting matrix metalloproteinases App 20040029945 - O'Brien, Patrick Michael ; et al. | 2004-02-12 |
| Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors Grant 6,686,355 - Barvian , et al. February 3, 2 | 2004-02-03 |
| 6,5-Fused bicyclic heterocycles App 20040014759 - Picard, Joseph Armand ; et al. | 2004-01-22 |
| Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors Grant 6,677,355 - Conrad , et al. January 13, 2 | 2004-01-13 |
| Matrix metalloproteinase inhibitors and their therapeutic uses Grant 6,624,177 - O'Brien , et al. September 23, 2 | 2003-09-23 |
| Method of inhibiting matrix metalloproteinases Grant 6,620,835 - O'Brien , et al. September 16, 2 | 2003-09-16 |
| Method of inhibiting matrix metalloproteinases App 20030032665 - O'Brien, Patrick Michael ; et al. | 2003-02-13 |
| Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors App 20020156074 - Barvian, Nicole Chantel ; et al. | 2002-10-24 |
| Tricyclic biphenyl sulfonamide matrix metalloproteinase inhibitors App 20020156071 - O'Brien, Patrick Michael ; et al. | 2002-10-24 |
| Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases Grant 6,350,885 - O'Brien , et al. February 26, 2 | 2002-02-26 |
| N-acyl sulfamic acid esters useful as hypocholesterolemic agents Grant 6,093,744 - Lee , et al. July 25, 2 | 2000-07-25 |
| Butyric acid matrix metalloproteinase inhibitors Grant 6,020,366 - Picard , et al. February 1, 2 | 2000-02-01 |
| Heterocyclic-substituted alkyl amide acat inhibitors Grant 5,693,657 - Lee , et al. December 2, 1 | 1997-12-02 |
| Isothiazolones lower plasma levels of lipoprotein(a) Grant 5,668,162 - Domagala , et al. September 16, 1 | 1997-09-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 